← DiscoverAI PREDICTION · 3-MONTH VIEW
IN
INBX
XNASInhibrx Biosciences, Inc.
Mkt Cap $1.2BBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FUNDAMENTALS
P/S
1051.92EV/EBITDA
-11.44P/B
-65.01EPS (TTM)
$-8.87ROE
618.9%ROA
-70.8%FCF
$-131.9MMKT CAP
$1.4BTECHNICAL ANALYSIS
Leaning Bearish
RSI-14
40.6
Neutral
MACD
0.000
Neutral
SMA-50
$-1.00
$-1.00
SMA-200
$-1.00
$-1.00
BOLL %B
0.23
Within bands
ATR-14
$7.19
RVOL
0.62x
Normal
MOMENTUM
-5.1%
10d -2.8% / 30d -11.4%
▲Strong edge over the market
INBX holds a similar standing over 1 and 3 months.
WHERE IT RANKS · vs 2,129 names
20-DAY
▲#19
60-DAY
▲Top 5%#99
TYPICAL 3-MO RANGE · vs S&P 500
+0.1%leans upper+1.1%
▸ Horizon detail
20d#19
60dTop 5%
1y+analyst mean$283.05+210.3%
⚡ AI INSIGHT
Our model reads INBX as strong both near-term and over the next few months. Analysts agree (78% Buy) — the bull case lines up.
ANALYST CONSENSUS
78% Buy
7 Buy2 Hold0 Sell
Low
$232
Mean
$283
High
$341
SHORT & FLOAT
Free Float
63.3%
9.9 days to cover.
Latest Headlines